Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 755

1.

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Porpaczy E, Tripolt S, Hoelbl-Kovacic A, Gisslinger B, Bago-Horvath Z, Casanova-Hevia E, Clappier E, Decker T, Fajmann S, Fux DA, Greiner G, Gueltekin S, Heller G, Herkner H, Hoermann G, Kiladjian JJ, Kolbe T, Kornauth C, Krauth MT, Kralovics R, Muellauer L, Mueller M, Prchal-Murphy M, Putz EM, Raffoux E, Schiefer AI, Schmetterer K, Schneckenleithner C, Simonitsch-Klupp I, Skrabs C, Sperr WR, Staber PB, Strobl B, Valent P, Jaeger U, Gisslinger H, Sexl V.

Blood. 2018 Jun 14. pii: blood-2017-10-810739. doi: 10.1182/blood-2017-10-810739. [Epub ahead of print]

PMID:
29907599
2.

CDK6 Antagonizes p53-Induced Responses during Tumorigenesis.

Bellutti F, Tigan AS, Nebenfuehr S, Dolezal M, Zojer M, Grausenburger R, Hartenberger S, Kollmann S, Doma E, Prchal-Murphy M, Uras IZ, Höllein A, Neuberg DS, Ebert BL, Ringler A, Mueller AC, Loizou JI, Hinds PW, Vogl C, Heller G, Kubicek S, Zuber J, Malumbres M, Farlik M, Villunger A, Kollmann K, Sexl V.

Cancer Discov. 2018 Jun 13. doi: 10.1158/2159-8290.CD-17-0912. [Epub ahead of print]

PMID:
29899063
3.

Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile.

Querfeld C, Leung S, Myskowski PL, Curran SA, Goldman DA, Heller G, Wu X, Kil SH, Sharma S, Finn KJ, Horwitz S, Moskowitz A, Mehrara B, Rosen ST, Halpern AC, Young JW.

Cancer Immunol Res. 2018 Jun 12. pii: canimm.0270.2017. doi: 10.1158/2326-6066.CIR-17-0270. [Epub ahead of print]

PMID:
29895574
4.

Reply to C. Ren et al.

Heller G, McCormack R, Kheoh T, Molina A, Smith MR, Dreicer R, Saad F, de Wit R, Aftab DT, Hirmand M, Limon-Carrera A, Fizazi K, Fleisher M, de Bono JS, Scher HI.

J Clin Oncol. 2018 Jun 12:JCO2018782672. doi: 10.1200/JCO.2018.78.2672. [Epub ahead of print] No abstract available.

PMID:
29894273
5.

Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes.

Zins K, Heller G, Mayerhofer M, Schreiber M, Abraham D.

Oncotarget. 2018 May 1;9(33):23126-23148. doi: 10.18632/oncotarget.25226. eCollection 2018 May 1.

6.

International Consortium of Vascular Registries Consensus Recommendations for Peripheral Revascularisation Registry Data Collection.

Behrendt CA, Bertges D, Eldrup N, Beck AW, Mani K, Venermo M, Szeberin Z, Menyhei G, Thomson I, Heller G, Wigger P, Danielsson G, Galzerano G, Lopez C, Altreuther M, Sigvant B, Rieß HC, Sedrakyan A, Beiles B, Björck M, Boyle JR, Debus ES, Cronenwett J.

Eur J Vasc Endovasc Surg. 2018 May 15. pii: S1078-5884(18)30213-2. doi: 10.1016/j.ejvs.2018.04.006. [Epub ahead of print]

PMID:
29776646
7.

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer.

Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA.

Oncolytic Virother. 2018 May 3;7:43-51. doi: 10.2147/OV.S155946. eCollection 2018.

8.

"Wish You Were Here": Examining Characteristics, Outcomes, and Statistical Solutions for Missing Cases in Web-Based Psychotherapeutic Trials.

Karin E, Dear BF, Heller GZ, Crane MF, Titov N.

JMIR Ment Health. 2018 Apr 19;5(2):e22. doi: 10.2196/mental.8363.

9.

Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, Cerqueira MD, deKemp RA, DePuey EG, Dilsizian V, Dorbala S, Ficaro EP, Garcia EV, Gewirtz H, Heller GV, Lewin HC, Malhotra S, Mann A, Ruddy TD, Schindler TH, Schwartz RG, Slomka PJ, Soman P, Di Carli MF.

J Nucl Cardiol. 2018 Apr 10. doi: 10.1007/s12350-018-1259-y. [Epub ahead of print]

PMID:
29637524
10.

Structural Ensemble Modulation upon Small-Molecule Binding to Disordered Proteins.

Heller GT, Bonomi M, Vendruscolo M.

J Mol Biol. 2018 Mar 26. pii: S0022-2836(18)30162-1. doi: 10.1016/j.jmb.2018.03.015. [Epub ahead of print] Review.

11.

DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients.

Heller G, Altenberger C, Steiner I, Topakian T, Ziegler B, Tomasich E, Lang G, End-Pfützenreuter A, Zehetmayer S, Döme B, Arns BM, Klepetko W, Zielinski CC, Zöchbauer-Müller S.

J Pathol. 2018 Mar 23. doi: 10.1002/path.5079. [Epub ahead of print]

PMID:
29570800
12.

Remodeling of the Feeding Arterial System After Surgery for Resection of Brain Arteriovenous Malformations: An Observational Study.

Morgan MK, Guilfoyle M, Kirollos R, Heller GZ.

Neurosurgery. 2018 Mar 12. doi: 10.1093/neuros/nyy007. [Epub ahead of print]

PMID:
29538752
13.

The role of embolization before surgery for Spetzler-Ponce Class B and C brain AVMs: a prospective cohort series.

Morgan MK, Heller GZ.

J Neurosurg Sci. 2018 Feb 23. doi: 10.23736/S0390-5616.18.04371-0. [Epub ahead of print]

PMID:
29480692
14.

Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials.

Heller G, McCormack R, Kheoh T, Molina A, Smith MR, Dreicer R, Saad F, de Wit R, Aftab DT, Hirmand M, Limon A, Fizazi K, Fleisher M, de Bono JS, Scher HI.

J Clin Oncol. 2018 Feb 20;36(6):572-580. doi: 10.1200/JCO.2017.75.2998. Epub 2017 Dec 22.

15.

Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, Cerqueira MD, deKemp RA, DePuey EG, Dilsizian V, Dorbala S, Ficaro EP, Garcia EV, Gewirtz H, Heller GV, Lewin HC, Malhotra S, Mann A, Ruddy TD, Schindler TH, Schwartz RG, Slomka PJ, Soman P, Di Carli MF, Einstein A, Russell R, Corbett JR.

J Nucl Cardiol. 2018 Feb;25(1):269-297. doi: 10.1007/s12350-017-1110-x. No abstract available. Erratum in: J Nucl Cardiol. 2018 Apr 10;:.

PMID:
29243073
16.

Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, Cerqueira MD, deKemp RA, DePuey EG, Dilsizian V, Dorbala S, Ficaro EP, Garcia EV, Gewirtz H, Heller GV, Lewin HC, Malhotra S, Mann A, Ruddy TD, Schindler TH, Schwartz RG, Slomka PJ, Soman P, Di Carli MF; SNMMI Cardiovascular Council Board of Directors; ASNC Board of Directors.

J Nucl Med. 2018 Feb;59(2):273-293. doi: 10.2967/jnumed.117.201368. Epub 2017 Dec 14. No abstract available.

PMID:
29242396
17.

Coronary risk equivalence of diabetes assessed by SPECT-MPI.

Morales DCV, Bhavnani SP, Ahlberg AW, Pullatt RC, Katten DM, Polk DM, Heller GV.

J Nucl Cardiol. 2017 Dec 6. doi: 10.1007/s12350-017-1114-6. [Epub ahead of print]

PMID:
29214611
18.

Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfalls.

Thallinger C, Füreder T, Preusser M, Heller G, Müllauer L, Höller C, Prosch H, Frank N, Swierzewski R, Berger W, Jäger U, Zielinski C.

Wien Klin Wochenschr. 2018 Feb;130(3-4):85-91. doi: 10.1007/s00508-017-1285-9. Epub 2017 Nov 2. Review.

19.

Identification of IL-40, a Novel B Cell-Associated Cytokine.

Catalan-Dibene J, Vazquez MI, Luu VP, Nuccio SP, Karimzadeh A, Kastenschmidt JM, Villalta SA, Ushach I, Pone EJ, Casali P, Raffatellu M, Burkhardt AM, Hernandez-Ruiz M, Heller G, Hevezi PA, Zlotnik A.

J Immunol. 2017 Nov 1;199(9):3326-3335. doi: 10.4049/jimmunol.1700534. Epub 2017 Oct 4.

PMID:
28978694
20.

[Memorandum III, Part 3: Quality of Care and Patient Safety Research Methods].

Geraedts M, Drösler SE, Döbler K, Eberlein-Gonska M, Heller G, Kuske S, Manser T, Sens B, Stausberg J, Schrappe M.

Gesundheitswesen. 2017 Oct;79(10):e95-e124. doi: 10.1055/s-0043-112431. Epub 2017 Sep 28. German.

21.

The German Aortic Valve Score II.

Schiller W, Barnewold L, Kazmaier T, Beckmann A, Masseli F, Welz A, Szecsenyi J, Heller G.

Eur J Cardiothorac Surg. 2017 Nov 1;52(5):881-887. doi: 10.1093/ejcts/ezx282.

PMID:
28950361
22.

Decision-to-Delivery Time and Perinatal Complications in Emergency Cesarean Section.

Heller G, Bauer E, Schill S, Thomas T, Louwen F, Wolff F, Misselwitz B, Schmidt S, Veit C.

Dtsch Arztebl Int. 2017 Sep 4;114(35-36):589-596. doi: 10.3238/arztebl.2017.0589.

23.

How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance.

Heller GZ, Manuguerra M, Chow R.

Scand J Pain. 2016 Oct;13:67-75. doi: 10.1016/j.sjpain.2016.06.012. Epub 2016 Jul 27. Review.

PMID:
28850536
24.

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.

Scher HI, Graf RP, Schreiber NA, McLaughlin B, Jendrisak A, Wang Y, Lee J, Greene S, Krupa R, Lu D, Bamford P, Louw JE, Dugan L, Vargas HA, Fleisher M, Landers M, Heller G, Dittamore R.

Cancer Res. 2017 Oct 15;77(20):5687-5698. doi: 10.1158/0008-5472.CAN-17-1353. Epub 2017 Aug 17.

PMID:
28819021
25.

Sequence Specificity in the Entropy-Driven Binding of a Small Molecule and a Disordered Peptide.

Heller GT, Aprile FA, Bonomi M, Camilloni C, De Simone A, Vendruscolo M.

J Mol Biol. 2017 Sep 1;429(18):2772-2779. doi: 10.1016/j.jmb.2017.07.016. Epub 2017 Jul 22.

26.

Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel.

Bianconi D, Heller G, Spies D, Herac M, Gleiss A, Liebmann-Reindl S, Unseld M, Kieler M, Scheithauer W, Streubel B, Zielinski CC, Prager GW.

Sci Rep. 2017 Jul 7;7(1):4851. doi: 10.1038/s41598-017-04743-0.

27.

Methods of probing the interactions between small molecules and disordered proteins.

Heller GT, Aprile FA, Vendruscolo M.

Cell Mol Life Sci. 2017 Sep;74(17):3225-3243. doi: 10.1007/s00018-017-2563-4. Epub 2017 Jun 19. Review.

28.

Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.

Taqueti VR, Dorbala S, Wolinsky D, Abbott B, Heller GV, Bateman TM, Mieres JH, Phillips LM, Wenger NK, Shaw LJ.

J Nucl Cardiol. 2017 Aug;24(4):1402-1426. doi: 10.1007/s12350-017-0926-8. Epub 2017 Jun 5.

29.

Status of cardiovascular PET radiation exposure and strategies for reduction: An Information Statement from the Cardiovascular PET Task Force.

Case JA, deKemp RA, Slomka PJ, Smith MF, Heller GV, Cerqueira MD.

J Nucl Cardiol. 2017 Aug;24(4):1427-1439. doi: 10.1007/s12350-017-0897-9. Epub 2017 May 16.

PMID:
28512722
30.

The Risk of Seizure Following Surgery for Brain Arteriovenous Malformation: A Prospective Cohort Study.

O'Donnell JM, Morgan MK, Heller GZ.

Neurosurgery. 2017 Dec 1;81(6):935-948. doi: 10.1093/neuros/nyx101.

PMID:
28368508
31.

Simultaneous quantification of protein order and disorder.

Sormanni P, Piovesan D, Heller GT, Bonomi M, Kukic P, Camilloni C, Fuxreiter M, Dosztanyi Z, Pappu RV, Babu MM, Longhi S, Tompa P, Dunker AK, Uversky VN, Tosatto SC, Vendruscolo M.

Nat Chem Biol. 2017 Mar 22;13(4):339-342. doi: 10.1038/nchembio.2331. No abstract available.

PMID:
28328918
32.

Editor's Choice - Carotid Stenosis Treatment: Variation in International Practice Patterns.

Venermo M, Wang G, Sedrakyan A, Mao J, Eldrup N, DeMartino R, Mani K, Altreuther M, Beiles B, Menyhei G, Danielsson G, Thomson I, Heller G, Setacci C, Björck M, Cronenwett J.

Eur J Vasc Endovasc Surg. 2017 Apr;53(4):511-519. doi: 10.1016/j.ejvs.2017.01.012. Epub 2017 Mar 6.

33.

A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity.

Perni M, Galvagnion C, Maltsev A, Meisl G, Müller MB, Challa PK, Kirkegaard JB, Flagmeier P, Cohen SI, Cascella R, Chen SW, Limbocker R, Sormanni P, Heller GT, Aprile FA, Cremades N, Cecchi C, Chiti F, Nollen EA, Knowles TP, Vendruscolo M, Bax A, Zasloff M, Dobson CM.

Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E1009-E1017. doi: 10.1073/pnas.1610586114. Epub 2017 Jan 17. Erratum in: Proc Natl Acad Sci U S A. 2017 Mar 21;114(12 ):E2543. Limboker, Ryan [corrected to Limbocker, Ryan].

34.

SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.

Altenberger C, Heller G, Ziegler B, Tomasich E, Marhold M, Topakian T, Müllauer L, Heffeter P, Lang G, End-Pfützenreuter A, Döme B, Arns BM, Klepetko W, Zielinski CC, Zöchbauer-Müller S.

Mol Cancer. 2017 Jan 5;16(1):1. doi: 10.1186/s12943-016-0568-5.

35.

Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.

Goldberg JD, Zheng J, Ratan R, Small TN, Lai KC, Boulad F, Castro-Malaspina H, Giralt SA, Jakubowski AA, Kernan NA, O'Reilly RJ, Papadopoulos EB, Young JW, van den Brink MR, Heller G, Perales MA.

Leuk Lymphoma. 2017 Aug;58(8):1859-1871. doi: 10.1080/10428194.2016.1265113. Epub 2017 Jan 10.

PMID:
28073320
36.

Principles of protein structural ensemble determination.

Bonomi M, Heller GT, Camilloni C, Vendruscolo M.

Curr Opin Struct Biol. 2017 Feb;42:106-116. doi: 10.1016/j.sbi.2016.12.004. Epub 2017 Jan 5. Review.

PMID:
28063280
37.

Microsurgery for Spetzler-Ponce Class A and B arteriovenous malformations utilizing an outcome score adopted from Gamma Knife radiosurgery: a prospective cohort study.

Morgan MK, Hermann Wiedmann MK, Stoodley MA, Heller GZ.

J Neurosurg. 2017 Nov;127(5):1105-1116. doi: 10.3171/2016.8.JNS161275. Epub 2016 Dec 23.

PMID:
28009228
38.

Deliberate employment of postoperative hypotension for brain arteriovenous malformation surgery and the incidence of delayed postoperative hemorrhage: a prospective cohort study.

Morgan MK, Wiedmann MKH, Assaad NNA, Parr MJA, Heller GZ.

J Neurosurg. 2017 Nov;127(5):1025-1040. doi: 10.3171/2016.9.JNS161333. Epub 2016 Dec 16.

PMID:
27982772
39.

Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.

Scher HI, Graf RP, Schreiber NA, McLaughlin B, Lu D, Louw J, Danila DC, Dugan L, Johnson A, Heller G, Fleisher M, Dittamore R.

Eur Urol. 2017 Jun;71(6):874-882. doi: 10.1016/j.eururo.2016.11.024. Epub 2016 Dec 12.

40.

Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade.

Curran SA, Shyer JA, St Angelo ET, Talbot LR, Sharma S, Chung DJ, Heller G, Hsu KC, Betts BC, Young JW.

Cancer Immunol Res. 2017 Jan;5(1):52-60. doi: 10.1158/2326-6066.CIR-16-0233. Epub 2016 Dec 6.

41.

A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer.

O'Shaughnessy MJ, McBride SM, Vargas HA, Touijer KA, Morris MJ, Danila DC, Laudone VP, Bochner BH, Sheinfeld J, Dayan ES, Bellomo LP, Sjoberg DD, Heller G, Zelefsky MJ, Eastham JA, Scardino PT, Scher HI.

Urology. 2017 Apr;102:164-172. doi: 10.1016/j.urology.2016.10.044. Epub 2016 Nov 22.

42.

Erratum to: American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET.

Bateman TM, Dilsizian V, Beanlands RS, DePuey EG, Heller GV, Wolinsky DA.

J Nucl Cardiol. 2017 Feb;24(1):332. doi: 10.1007/s12350-016-0716-8. No abstract available.

PMID:
27830433
44.

Time to get on the stress-only bandwagon?

Parker MW, Heller GV.

J Nucl Cardiol. 2018 Jun;25(3):817-819. doi: 10.1007/s12350-016-0691-0. Epub 2016 Oct 14. No abstract available.

PMID:
27743295
45.

The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population.

Heller G, Fizazi K, McCormack R, Molina A, MacLean D, Webb IJ, Saad F, de Bono JS, Scher HI.

Clin Cancer Res. 2017 Apr 15;23(8):1967-1973. doi: 10.1158/1078-0432.CCR-16-1224. Epub 2016 Sep 27.

46.

Do ENT outpatient computed tomography facilities perceive accreditation as valuable?

Farrell MB, Zhao A, Heller G, Setzen G.

Ear Nose Throat J. 2016 Sep;95(9):364-7. No abstract available.

PMID:
27657312
47.

Inference for the difference in the area under the ROC curve derived from nested binary regression models.

Heller G, Seshan VE, Moskowitz CS, Gönen M.

Biostatistics. 2017 Apr 1;18(2):260-274. doi: 10.1093/biostatistics/kxw045.

48.

Transdural arterial recruitment to brain arteriovenous malformation: clinical and management implications in a prospective cohort series.

Bervini D, Morgan MK, Stoodley MA, Heller GZ.

J Neurosurg. 2017 Jul;127(1):51-58. doi: 10.3171/2016.5.JNS16730. Epub 2016 Sep 2.

PMID:
27588588
49.

American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET.

Bateman TM, Dilsizian V, Beanlands RS, DePuey EG, Heller GV, Wolinsky DA.

J Nucl Med. 2016 Oct;57(10):1654-1656. Epub 2016 Aug 25. No abstract available.

50.

First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.

Pandit-Taskar N, O'Donoghue JA, Ruan S, Lyashchenko SK, Carrasquillo JA, Heller G, Martinez DF, Cheal SM, Lewis JS, Fleisher M, Keppler JS, Reiter RE, Wu AM, Weber WA, Scher HI, Larson SM, Morris MJ.

J Nucl Med. 2016 Dec;57(12):1858-1864. Epub 2016 Aug 11.

Supplemental Content

Loading ...
Support Center